RIL
NVCR icon

Rothschild Investment LLC’s NovoCure NVCR Stock Holding History

Rothschild Investment LLC’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.3K Buy
482
+290
+151% +$4.39K ﹤0.01% 2064
2026
Q1 		$2.09K Sell
192
-30
-14% -$375 ﹤0.01% 2542
2025
Q4 		$2.87K Buy
222
+107
+93% +$1.37K ﹤0.01% 2184
2025
Q3 		$1.49K Sell
115
-55
-32% -$735 ﹤0.01% 2401
2025
Q2 		$3.03K Sell
170
-20
-11% -$349 ﹤0.01% 1783
2025
Q1 		$3.39K Buy
190
+70
+58% +$1.59K ﹤0.01% 1620
2024
Q4 		$3.58K Buy
120
+25
+26% +$529 ﹤0.01% 1479
2024
Q3 		$1.49K Buy
95
+85
+850% +$1.54K ﹤0.01% 1890
2024
Q2 		$171 Buy
+10
New +$176 ﹤0.01% 2538

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Rothschild Investment LLC's NVCR Position: Q2 2026 in Review

Rothschild Investment LLC increased its NovoCure (NVCR) stake by 151% in Q2 2026, buying an estimated $4.39K and bringing the position to 482 shares worth $7.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2064.

Rothschild Investment LLC first reported a position in NVCR in Q2 2024 and has held it in 9 quarters since. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Rothschild Investment LLC held 482 shares of NovoCure worth $7.3K as of Q2 2026.
  • Rothschild Investment LLC bought 290 NovoCure shares in Q2 2026, an estimated $4.39K.
  • NovoCure made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2064 holding.
  • Rothschild Investment LLC first reported a position in NovoCure in Q2 2024 and has held it in 9 quarters since.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.